GO
Loading...

Bristol-Myers Squibb Co

More

  • Early Glance: Pharmaceuticals companies Monday, 24 Nov 2014 | 10:27 AM ET

    Baxter International Inc. fell$. 07 or. 1 percent, to $72.37. Hospira rose$. 13 or. 2 percent, to $58.95. Johnson& Johnson fell$. 17 or. 2 percent, to $107.69.

  • Final Glance: Pharmaceuticals companies Friday, 21 Nov 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $72.44. Bristol-Myers Squibb Co. rose$. 19 or. 3 percent, to $58.80. Hospira rose$. 29 or. 5 percent, to $58.82.

  • Early Glance: Pharmaceuticals companies Friday, 21 Nov 2014 | 10:18 AM ET

    Baxter International Inc. rose$. 74 or 1.0 percent, to $72.73. Bristol-Myers Squibb Co. rose$. 53 or. 9 percent, to $59.14. Hospira rose$. 58 or 1.0 percent, to $59.11.

  • Final Glance: Pharmaceuticals companies Thursday, 20 Nov 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 47 or. 6 percent, to $71.99. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $58.61. Hospira fell$. 28 or. 5 percent, to $58.53.

  • Midday Glance: Pharmaceuticals companies Thursday, 20 Nov 2014 | 2:49 PM ET

    Baxter International Inc. fell$. 72 or 1.0 percent, to $71.74. Bristol-Myers Squibb Co. fell$. 23 or. 4 percent, to $58.58. Hospira fell$. 33 or. 6 percent, to $58.48.

  • Early Glance: Pharmaceuticals companies Thursday, 20 Nov 2014 | 10:29 AM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $71.92. Bristol-Myers Squibb Co. fell$. 37 or. 6 percent, to $58.44. Hospira rose$. 11 or. 2 percent, to $58.92.

  • Final Glance: Pharmaceuticals companies Wednesday, 19 Nov 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $72.46. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $58.81. Hospira fell$. 91 or 1.5 percent, to $58.81.

  • Midday Glance: Pharmaceuticals companies Wednesday, 19 Nov 2014 | 1:31 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $72.46. Bristol-Myers Squibb Co. fell$. 13 or. 2 percent, to $58.57. Hospira fell $1.03 or 1.7 percent, to $58.69.

  • Early Glance: Pharmaceuticals companies Wednesday, 19 Nov 2014 | 12:01 PM ET

    Baxter International Inc. fell$. 02 or percent, to $72.56. Bristol-Myers Squibb Co. fell$. 23 or. 4 percent, to $58.47. Hospira fell$. 47 or. 8 percent, to $59.25.

  • Final Glance: Pharmaceuticals companies Tuesday, 18 Nov 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 58 or. 8 percent, to $72.58. Bristol-Myers Squibb Co. rose$. 27 or. 5 percent, to $58.70. Pfizer rose$. 27 or. 9 percent, to $30.59.

  • Midday Glance: Pharmaceuticals companies Tuesday, 18 Nov 2014 | 1:25 PM ET

    Baxter International Inc. rose$. 21 or. 3 percent, to $72.21. Bristol-Myers Squibb Co. rose$. 23 or. 4 percent, to $58.66. Hospira rose $1.03 or 1.8 percent, to $59.44.

  • Early Glance: Pharmaceuticals companies Tuesday, 18 Nov 2014 | 10:23 AM ET

    Baxter International Inc. rose$. 14 or. 2 percent, to $72.14. Bristol-Myers Squibb Co. rose$. 46 or. 8 percent, to $58.89. Hospira rose$. 80 or 1.4 percent, to $59.20.

  • Final Glance: Pharmaceuticals companies Monday, 17 Nov 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 25 or. 3 percent, to $72.00. Bristol-Myers Squibb Co. rose$. 48 or. 8 percent, to $58.43. Hospira rose$. 12 or. 2 percent, to $58.40.

  • Midday Glance: Pharmaceuticals companies Monday, 17 Nov 2014 | 2:21 PM ET

    Baxter International Inc. rose$. 16 or. 2 percent, to $71.91. Bristol-Myers Squibb Co. rose$. 30 or. 5 percent, to $58.25. Hospira rose$. 23 or. 4 percent, to $58.51.

  • US, German drugmakers team up on cancer medicines Monday, 17 Nov 2014 | 1:47 PM ET

    Under their agreement, New York- based Pfizer will pay Merck KGaA $850 million initially and up to $2 billion total, based on how many drugs are approved and future revenue levels. Pfizer said it will take a charge for the $850 million payment, cutting into profit this year, so it's lowered its 2014 earnings forecast by a dime, to a range of $1.40 to $1.49 per share.

  • Early Glance: Pharmaceuticals companies Monday, 17 Nov 2014 | 10:29 AM ET

    Baxter International Inc. fell$. 14 or. 2 percent, to $71.61. Bristol-Myers Squibb Co. rose$. 22 or. 4 percent, to $58.17. Hospira rose$. 12 or. 2 percent, to $58.40.

  • BUSINESS-NEWS-SCHEDULE AT 2200 GMT / 5 PM ET Sunday, 16 Nov 2014 | 4:46 PM ET

    WASHINGTON- President Barack Obama defends the transparency of his signature healthcare law after a White House adviser on the reform said the law passed, in part, because of the "stupidity" of American voters. ALLERGAN, ACTAVIS NEAR DEAL, ANNOUNCEMENT AS EARLY AS MONDAY. NEW YORK- Allergan nears a deal to merge with Actavis Plc, with an announcement coming as soon as...

  • Nov 16- Chemotherapy as a treatment for advanced melanoma could soon become obsolete, researchers said on Sunday, after patients taking an experimental immuno-oncology drug from Bristol-Myers Squibb Co had a much higher survival rate and had other favorable results. Georgina Long, an associate professor at the Melanoma Institute Australia who helped lead...

  • Final Glance: Pharmaceuticals companies Friday, 14 Nov 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 33 or. 5 percent, to $71.75. Bristol-Myers Squibb Co. rose$. 15 or. 3 percent, to $57.95. Hospira rose$. 19 or. 3 percent, to $58.28.

  • Midday Glance: Pharmaceuticals companies Friday, 14 Nov 2014 | 1:17 PM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $71.77. Bristol-Myers Squibb Co. fell$. 03 or. 1 percent, to $57.77. Hospira fell$. 08 or. 1 percent, to $58.01.